share_log

中关村(000931.SZ)下属公司北京华素药品生产许可证变更及通过药品GMP符合性检查

A subsidiary company of Zhongguancun (000931.SZ) changed the production license of Beijing Huasu Pharmaceutical and passed the drug GMP compliance inspection

Zhitong Finance ·  Feb 7 04:09

Zhongguancun (000931.SZ) issued an announcement. The company's subsidiary, Beijing Huasu Pharmaceutical Co., Ltd. (Beijing Hua...

Zhitong Finance App News, Zhongguancun (000931.SZ) issued an announcement. Beijing Huasu Pharmaceutical Co., Ltd. (Beijing Huasu), a subsidiary of the company, recently received the “Pharmaceutical Production License” (license number: Beijing 20150168) and “Drug GMP Compliance Inspection Notice” (ID: Beijing Pharmaceutical Regulatory GMP [2023] 020095) issued by the Beijing Drug Administration.

The “Pharmaceutical Production License” change involves a change in the production site for the API naloxone hydrochloride; the “Pharmaceutical GMP Compliance Inspection Notice” inspection concluded that the naloxone hydrochloride production line complied with the “Pharmaceutical Production Quality Management Code (2010 Revision)” and appendix requirements.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment